agastiyabiotech.comAbout company
Agastiya Biotech is a new drug development company delivering innovative pharmaceutical products to the marketplace. The company’s innovative methodologies have created several novel small molecules with patents for different types of cancer including the most challenging leukemia and pancreatic cancer. They developing novel molecular formulations for breakthrough therapies in cancer stem cells, tumor suppressor genes, and oncogene mutations. Agastiya Biotech pipeline is focused on areas for which the unmet medical need is greatest and for which there are few effective therapies. The company has discovered its previously tested anti-cancer small molecule AB001 to be working as well for SARS-CoV-2 virus therapeutics in silico studies. Agastiya Biotech was founded in 2019 and is based in Temecula, California, USA.
